Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Drug-Induced Nitric Oxide Kills Latent Tuberculosis Bacteria

By LabMedica International staff writers
Posted on 08 Dec 2008
The experimental bicyclic nitroimidazole pro-drug PA-824, which requires intracellular activation to trigger its biological function, has been found to effectively kill the latent form of the tuberculosis bacterium Mycobacterium tuberculosis.

Control of tuberculosis, which infects nearly one-third of the world's population, requires killing both the active and latent forms of the causative organism, M. More...
tuberculosis. Attacking the latent form has proven to be especially difficult, as drugs that effect the bacteria's metabolism are not of any use.

In the current study, which was published in the November 28, 2008, issue of the journal Science, investigators at the [U.S.] National Institutes of Health (Bethesda, MD, USA) identified an M. tuberculosis enzyme, deazaflavin-dependent nitroreductase (Ddn), that converted PA-824 into three primary metabolites; the major one being the corresponding des-nitroimidazole (des-nitro). Des-nitro metabolite formation generated reactive nitrogen species, including nitric oxide (NO), which killed the bacteria. Since humans have no enzymes equivalent to Ddn, PA-824 has no effect on human cells.

"It took several years, but at last we were able to recreate in the test tube what happens inside mycobacterial cells when the bacterial enzyme, which we named Ddn, and a second bacterial component called a cofactor, interact with PA-824,” explained senior author Dr. Clifton Barry, a senior researcher at the National Institutes of Health. "This highly reactive molecule is akin to a bomb blast that kills the bacteria from within.”

Related Links:

National Institutes of Health


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.